+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-tumor Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
Anti-tumor Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
New

Anti-tumor Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 110 Pages
  • January 2025
  • Region: Global
  • Prof Research
  • ID: 5950742
Description Jump to:
The global anti-tumor injection market has emerged as a critical component of cancer treatment, providing targeted therapies that improve patient outcomes and quality of life. As of 2023, the market has been witnessing substantial growth, driven by an increase in cancer prevalence, advancements in drug formulations, and a robust pipeline of innovative treatments. Various types of anti-tumor injections are available in the market, including but not limited to Docetaxel Injectables, Paclitaxel Injectables, Bevacizumab Injectables, Adalimumab Injectables, and Rituximab Injectables.

Market Size and Share

The global anti-tumor injection market was valued at approximately $60 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2030. By the end of the forecast period, the market size is projected to exceed $90 billion.

Trends Analysis Report by Product Type

The anti-tumor injection market is classified according to product types as follows:
  • Docetaxel Injection: Dominating the market, Docetaxel injections accounted for approximately 30% of the total market share in 2023.
  • Paclitaxel Injection: Another major contributor, Paclitaxel injections had a market share of about 25%.
  • Bevacizumab Injection: Representing nearly 15%, Bevacizumab injections are increasingly being used due to their efficacy.
  • Adalimumab Injection: Holding roughly 10% of the market share, Adalimumab is noted for treating various cancers effectively.
  • Rituximab Injection: Contributing about 8% to the market, Rituximab remains a key player in lymphatic cancers.
  • Others: This category, which includes various less common injections, accounted for the remaining 12%.

Key Players

The competitive landscape of the anti-tumor injection market is characterized by key players who dominate the market through innovation and strategic partnerships. Major companies include:
  • Roche
  • Bayer
  • Novartis
  • Pfizer
  • Amgen
  • Mabxience
  • Luoxin Pharmaceutical
  • Qilu Pharmaceutical
  • Zhejiang Borui Biopharmaceutical
  • Fuxing Medicine
  • Yuekang Pharmaceutical
  • Yuheng Pharmaceutical
  • Hengrui Medicine
  • Huiyu Pharmaceutical
  • Changbaishan Pharmaceutical
  • Innovent Biologics
  • Yifan Pharmaceutical

Market Segmentation by Process and Application

The anti-tumor injection market is further segmented based on process and application:

By Process

  • Reconstitution of Lyophilized Injectable Drugs
  • Concentration and Dilution of Injectable Solutions
  • Preparation of Infusion Solutions
  • Others

By Application

  • Breast Cancer: The leading application segment, accounting for approximately 35% of the market.
  • Stomach Cancer: Contributing about 15% of total sales.
  • Ovarian Cancer: Representing roughly 10%.
  • Lung Cancer: This application holds 12%.
  • Testicular Cancer: Serves as an application for about 7%.
  • Cervical Cancer: Contributing 6%.
  • Endometrial Cancer: About 5%.
  • Prostate Cancer: Also around 5%.
  • Bladder Cancer: Similarly contributes around 5%.
  • Others: Including rarer forms of cancer, share 4%.

Market Segmentation by End-Use

The end-use segment includes:
  • Hospitals: Leading the segment, responsible for approximately 60% of total consumption.
  • Oncology Clinics: Holding about 25% of the market.
  • Homecare Settings: Account for 15%.

Regional Analysis

The anti-tumor injection market is worldwide, with significant regional insights as follows:
  • North America: Holds the largest market share at approximately 40% due to the high prevalence of cancer and advanced healthcare facilities.
  • Europe: Closely follows North America, representing about 30%.
  • Asia-Pacific: Expected to exhibit a rapid growth rate, estimated at around 20% of the total market.
  • Latin America: Contributes about 5%.
  • Middle East & Africa: Accounts for roughly 5%.

Market News: Policy and Company Developments

The anti-tumor injection market is influenced by numerous policies and developments:
  • In 2023, the FDA approved several new anti-tumor injections, expanding the treatment options available to patients and enhancing market potential.
  • Many companies are engaging in strategic collaborations to accelerate research and development, especially in immunotherapies and personalized medicine.
  • Government policies promoting access to cancer treatments and reimbursement schemes have a positive impact on market growth.

Market Forecasts (2025 - 2030)

Looking ahead, the anti-tumor injection market is expected to continue its growth trajectory. Key forecasts include:
  • By 2030, the market is expected to surpass $90 billion.
  • Docetaxel and Paclitaxel injections will likely remain the top revenue generators.
  • Emerging therapies and innovative products tailored for specific cancers are expected to gain traction during this period.
  • The Asia-Pacific region is projected to witness the highest growth rate, driven by increasing cancer awareness and improved healthcare infrastructure.

Conclusion

The anti-tumor injection market shows promising growth prospects from 2025 to 2030, underpinned by advancements in pharmaceuticals, rising cancer incidences, and policy support promoting better treatment options.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Anti-Tumor Injection Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Anti-Tumor Injection Market in North America (2020-2030)
8.1 Anti-Tumor Injection Market Size
8.2 Anti-Tumor Injection Market by End Use
8.3 Competition by Players/Suppliers
8.4 Anti-Tumor Injection Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Anti-Tumor Injection Market in South America (2020-2030)
9.1 Anti-Tumor Injection Market Size
9.2 Anti-Tumor Injection Market by End Use
9.3 Competition by Players/Suppliers
9.4 Anti-Tumor Injection Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Anti-Tumor Injection Market in Asia & Pacific (2020-2030)
10.1 Anti-Tumor Injection Market Size
10.2 Anti-Tumor Injection Market by End Use
10.3 Competition by Players/Suppliers
10.4 Anti-Tumor Injection Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Anti-Tumor Injection Market in Europe (2020-2030)
11.1 Anti-Tumor Injection Market Size
11.2 Anti-Tumor Injection Market by End Use
11.3 Competition by Players/Suppliers
11.4 Anti-Tumor Injection Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Anti-Tumor Injection Market in MEA (2020-2030)
12.1 Anti-Tumor Injection Market Size
12.2 Anti-Tumor Injection Market by End Use
12.3 Competition by Players/Suppliers
12.4 Anti-Tumor Injection Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Anti-Tumor Injection Market (2020-2025)
13.1 Anti-Tumor Injection Market Size
13.2 Anti-Tumor Injection Market by End Use
13.3 Competition by Players/Suppliers
13.4 Anti-Tumor Injection Market Size by Type
Chapter 14 Global Anti-Tumor Injection Market Forecast (2025-2030)
14.1 Anti-Tumor Injection Market Size Forecast
14.2 Anti-Tumor Injection Application Forecast
14.3 Competition by Players/Suppliers
14.4 Anti-Tumor Injection Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Roche
15.1.1 Company Profile
15.1.2 Main Business and Anti-tumor Injection Information
15.1.3 SWOT Analysis of Roche
15.1.4 Roche Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.2 Bayer
15.2.1 Company Profile
15.2.2 Main Business and Anti-tumor Injection Information
15.2.3 SWOT Analysis of Bayer
15.2.4 Bayer Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.3 Novartis
15.3.1 Company Profile
15.3.2 Main Business and Anti-tumor Injection Information
15.3.3 SWOT Analysis of Novartis
15.3.4 Novartis Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.4 Pfizer
15.4.1 Company Profile
15.4.2 Main Business and Anti-tumor Injection Information
15.4.3 SWOT Analysis of Pfizer
15.4.4 Pfizer Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.5 Amgen
15.5.1 Company Profile
15.5.2 Main Business and Anti-tumor Injection Information
15.5.3 SWOT Analysis of Amgen
15.5.4 Amgen Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.6 Mabxience
15.6.1 Company Profile
15.6.2 Main Business and Anti-tumor Injection Information
15.6.3 SWOT Analysis of Mabxience
15.6.4 Mabxience Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.7 Luoxin Pharmaceutical
15.7.1 Company Profile
15.7.2 Main Business and Anti-tumor Injection Information
15.7.3 SWOT Analysis of Luoxin Pharmaceutical
15.7.4 Luoxin Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.8 Qilu Pharmaceutical
15.8.1 Company Profile
15.8.2 Main Business and Anti-tumor Injection Information
15.8.3 SWOT Analysis of Qilu Pharmaceutical
15.8.4 Qilu Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.9 Zhejiang Borui Biopharmaceutical
15.9.1 Company Profile
15.9.2 Main Business and Anti-tumor Injection Information
15.9.3 SWOT Analysis of Zhejiang Borui Biopharmaceutical
15.9.4 Zhejiang Borui Biopharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.10 Fuxing Medicine
15.10.1 Company Profile
15.10.2 Main Business and Anti-tumor Injection Information
15.10.3 SWOT Analysis of Fuxing Medicine
15.10.4 Fuxing Medicine Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.11 Yuekang Pharmaceutical
15.11.1 Company Profile
15.11.2 Main Business and Anti-tumor Injection Information
15.11.3 SWOT Analysis of Yuekang Pharmaceutical
15.11.4 Yuekang Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.12 Yuheng Pharmaceutical
15.12.1 Company Profile
15.12.2 Main Business and Anti-tumor Injection Information
15.12.3 SWOT Analysis of Yuheng Pharmaceutical
15.12.4 Yuheng Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.13 Hengrui Medicine
15.13.1 Company Profile
15.13.2 Main Business and Anti-tumor Injection Information
15.13.3 SWOT Analysis of Hengrui Medicine
15.13.4 Hengrui Medicine Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.14 Huiyu Pharmaceutical
15.14.1 Company Profile
15.14.2 Main Business and Anti-tumor Injection Information
15.14.3 SWOT Analysis of Huiyu Pharmaceutical
15.14.4 Huiyu Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.15 Changbaishan Pharmaceutical
15.15.1 Company Profile
15.15.2 Main Business and Anti-tumor Injection Information
15.15.3 SWOT Analysis of Changbaishan Pharmaceutical
15.15.4 Changbaishan Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.16 Innovent Biologics
15.16.1 Company Profile
15.16.2 Main Business and Anti-tumor Injection Information
15.16.3 SWOT Analysis of Innovent Biologics
15.16.4 Innovent Biologics Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.17 Yifan Pharmaceutical
15.17.1 Company Profile
15.17.2 Main Business and Anti-tumor Injection Information
15.17.3 SWOT Analysis of Yifan Pharmaceutical
15.17.4 Yifan Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Anti-Tumor Injection Report
Table Data Sources of Anti-Tumor Injection Report
Table Major Assumptions of Anti-Tumor Injection Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Anti-Tumor Injection Picture
Table Anti-Tumor Injection Classification
Table Anti-Tumor Injection Applications
Table Drivers of Anti-Tumor Injection Market
Table Restraints of Anti-Tumor Injection Market
Table Opportunities of Anti-Tumor Injection Market
Table Threats of Anti-Tumor Injection Market
Table COVID-19 Impact For Anti-Tumor Injection Market
Table Raw Materials Suppliers
Table Different Production Methods of Anti-Tumor Injection
Table Cost Structure Analysis of Anti-Tumor Injection
Table Key End Users
Table Latest News of Anti-Tumor Injection Market
Table Merger and Acquisition
Table Planned/Future Project of Anti-Tumor Injection Market
Table Policy of Anti-Tumor Injection Market
Table 2020-2030 North America Anti-Tumor Injection Market Size
Figure 2020-2030 North America Anti-Tumor Injection Market Size and CAGR
Table 2020-2030 North America Anti-Tumor Injection Market Size by Application
Table 2020-2025 North America Anti-Tumor Injection Key Players Revenue
Table 2020-2025 North America Anti-Tumor Injection Key Players Market Share
Table 2020-2030 North America Anti-Tumor Injection Market Size by Type
Table 2020-2030 United States Anti-Tumor Injection Market Size
Table 2020-2030 Canada Anti-Tumor Injection Market Size
Table 2020-2030 Mexico Anti-Tumor Injection Market Size
Table 2020-2030 South America Anti-Tumor Injection Market Size
Figure 2020-2030 South America Anti-Tumor Injection Market Size and CAGR
Table 2020-2030 South America Anti-Tumor Injection Market Size by Application
Table 2020-2025 South America Anti-Tumor Injection Key Players Revenue
Table 2020-2025 South America Anti-Tumor Injection Key Players Market Share
Table 2020-2030 South America Anti-Tumor Injection Market Size by Type
Table 2020-2030 Brazil Anti-Tumor Injection Market Size
Table 2020-2030 Argentina Anti-Tumor Injection Market Size
Table 2020-2030 Chile Anti-Tumor Injection Market Size
Table 2020-2030 Peru Anti-Tumor Injection Market Size
Table 2020-2030 Asia & Pacific Anti-Tumor Injection Market Size
Figure 2020-2030 Asia & Pacific Anti-Tumor Injection Market Size and CAGR
Table 2020-2030 Asia & Pacific Anti-Tumor Injection Market Size by Application
Table 2020-2025 Asia & Pacific Anti-Tumor Injection Key Players Revenue
Table 2020-2025 Asia & Pacific Anti-Tumor Injection Key Players Market Share
Table 2020-2030 Asia & Pacific Anti-Tumor Injection Market Size by Type
Table 2020-2030 China Anti-Tumor Injection Market Size
Table 2020-2030 India Anti-Tumor Injection Market Size
Table 2020-2030 Japan Anti-Tumor Injection Market Size
Table 2020-2030 South Korea Anti-Tumor Injection Market Size
Table 2020-2030 Southeast Asia Anti-Tumor Injection Market Size
Table 2020-2030 Australia Anti-Tumor Injection Market Size
Table 2020-2030 Europe Anti-Tumor Injection Market Size
Figure 2020-2030 Europe Anti-Tumor Injection Market Size and CAGR
Table 2020-2030 Europe Anti-Tumor Injection Market Size by Application
Table 2020-2025 Europe Anti-Tumor Injection Key Players Revenue
Table 2020-2025 Europe Anti-Tumor Injection Key Players Market Share
Table 2020-2030 Europe Anti-Tumor Injection Market Size by Type
Table 2020-2030 Germany Anti-Tumor Injection Market Size
Table 2020-2030 France Anti-Tumor Injection Market Size
Table 2020-2030 United Kingdom Anti-Tumor Injection Market Size
Table 2020-2030 Italy Anti-Tumor Injection Market Size
Table 2020-2030 Spain Anti-Tumor Injection Market Size
Table 2020-2030 Belgium Anti-Tumor Injection Market Size
Table 2020-2030 Netherlands Anti-Tumor Injection Market Size
Table 2020-2030 Austria Anti-Tumor Injection Market Size
Table 2020-2030 Poland Anti-Tumor Injection Market Size
Table 2020-2030 Russia Anti-Tumor Injection Market Size
Table 2020-2030 MEA Anti-Tumor Injection Market Size
Figure 2020-2030 MEA Anti-Tumor Injection Market Size and CAGR
Table 2020-2030 MEA Anti-Tumor Injection Market Size by Application
Table 2020-2025 MEA Anti-Tumor Injection Key Players Revenue
Table 2020-2025 MEA Anti-Tumor Injection Key Players Market Share
Table 2020-2030 MEA Anti-Tumor Injection Market Size by Type
Table 2020-2030 Egypt Anti-Tumor Injection Market Size
Table 2020-2030 Israel Anti-Tumor Injection Market Size
Table 2020-2030 South Africa Anti-Tumor Injection Market Size
Table 2020-2030 Gulf Cooperation Council Countries Anti-Tumor Injection Market Size
Table 2020-2030 Turkey Anti-Tumor Injection Market Size
Table 2020-2025 Global Anti-Tumor Injection Market Size by Region
Table 2020-2025 Global Anti-Tumor Injection Market Size Share by Region
Table 2020-2025 Global Anti-Tumor Injection Market Size by Application
Table 2020-2025 Global Anti-Tumor Injection Market Share by Application
Table 2020-2025 Global Anti-Tumor Injection Key Vendors Revenue
Figure 2020-2025 Global Anti-Tumor Injection Market Size and Growth Rate
Table 2020-2025 Global Anti-Tumor Injection Key Vendors Market Share
Table 2020-2025 Global Anti-Tumor Injection Market Size by Type
Table 2020-2025 Global Anti-Tumor Injection Market Share by Type
Table 2025-2030 Global Anti-Tumor Injection Market Size by Region
Table 2025-2030 Global Anti-Tumor Injection Market Size Share by Region
Table 2025-2030 Global Anti-Tumor Injection Market Size by Application
Table 2025-2030 Global Anti-Tumor Injection Market Share by Application
Table 2025-2030 Global Anti-Tumor Injection Key Vendors Revenue
Figure 2025-2030 Global Anti-Tumor Injection Market Size and Growth Rate
Table 2025-2030 Global Anti-Tumor Injection Key Vendors Market Share
Table 2025-2030 Global Anti-Tumor Injection Market Size by Type
Table 2025-2030 Anti-Tumor Injection Global Market Share by Type

Companies Mentioned

  • Roche
  • Bayer
  • Novartis
  • Pfizer
  • Amgen
  • Mabxience
  • Luoxin Pharmaceutical
  • Qilu Pharmaceutical
  • Zhejiang Borui Biopharmaceutical
  • Fuxing Medicine
  • Yuekang Pharmaceutical
  • Yuheng Pharmaceutical
  • Hengrui Medicine
  • Huiyu Pharmaceutical
  • Changbaishan Pharmaceutical
  • Innovent Biologics
  • Yifan Pharmaceutical

Related Topics

Related Reports

Bacteriostatic Water for Injection Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Bacteriostatic Water for Injection Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Paclitaxel Injection Global Market Report 2024 - Product Image

Paclitaxel Injection Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Bacteriostatic Water for Injection Market by Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Bacteriostatic Water for Injection Market by Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Aztreonam Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Aztreonam Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 89 Pages
  • Global
From
Self-Injections Global Market Report 2024 - Product Image

Self-Injections Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.